活化性CD8+ T细胞在不明原因儿童急性肝衰竭中的研究进展
Research Progress of Activated CD8+ T Cells in Indeterminate Pediatric Acute Liver Failure
DOI: 10.12677/ACM.2024.142525, PDF,    科研立项经费支持
作者: 冉小姗, 詹 学*:重庆医科大学附属儿童医院消化科,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,儿科学重庆市重点实验室,重庆 ;刘小乖:西安市儿童医院感染科,陕西 西安
关键词: 儿童急性肝衰竭病因诊断不明组织驻留记忆T细胞免疫失调Pediatric Acute Liver Failure Etiology Indeterminate Diagnosis Tissue-Resident Memory T Cells Immune Dysregulation
摘要: 儿童急性肝衰竭(PALF)是一种起病急骤,进展迅速,累及多个系统的临床综合征,目前仍有30%~50%患者尚无法明确病因,称为不明原因儿童急性肝衰竭(iPALF)。虽然这类患者发病机制尚不明确,但越来越多的证据表明,免疫失调在其中起到了极为重要的作用,近年来有研究发现肝脏组织记忆CD8+ T淋巴细胞(CD8+ TRM)与iPALF的发生发展密切相关。本文综述了活化性CD8+ T细胞及其相关炎症通路在iPALF中的作用机制,以期为iPALF患者的临床诊疗,预后判断及治疗方法提供新思路。
Abstract: Pediatric acute liver failure (PALF) is a clinical syndrome with rapid onset, rapid progression, and multiple systems. In up to 30%~50% of cases of pediatric acute liver failure no known etiology and pathogenesis can be found, and are referred to as indeterminate pediatric acute liver failure (iPALF). Although the pathogenesis in these patients is not well understood, there is growing evi-dence that immune dysregulation is extremely important in it. In recent years, it has been found that Tissue-resident memory T cells (CD8+ TRM) are closely associated with the development of iPALF. The mechanism of activated CD8+ T cells and their related inflammatory pathways and im-mune pathways were reviewed, in order to provide new ideas for clinical diagnosis and treatment, prognosis and therapeutic approaches for patients with iPALF.
文章引用:冉小姗, 刘小乖, 詹学. 活化性CD8+ T细胞在不明原因儿童急性肝衰竭中的研究进展[J]. 临床医学进展, 2024, 14(2): 3764-3771. https://doi.org/10.12677/ACM.2024.142525

参考文献

[1] 谢新宝, 王建设. 重视儿童急性肝衰竭的诊治[J]. 临床肝胆病杂志, 2022, 38(2): 257-259.
[2] Narkewicz, M.R., Horslen, S., Hardison, R.M., et al. (2018) A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients. Clinical Gastroenterology and Hepatology, 16, 1801-1810.e3.
[3] Zamora, R., Vodovotz, Y., Mi, Q., et al. (2017) Data-Driven Modeling for Precision Medicine in Pediatric Acute Liver Failure. Molecular Medicine, 22, 821-829. [Google Scholar] [CrossRef] [PubMed]
[4] Alonso, E.M., Horslen, S.P., Behrens, E.M., et al. (2017) Pediatric Acute Liver Failure of Undetermined Cause: A Research Workshop. Hepatology, 65, 1026-1037. [Google Scholar] [CrossRef] [PubMed]
[5] McKenzie, R.B., Berquist, W.E., Nadeau, K.C., et al. (2014) Novel Protocol Including Liver Biopsy to Identify and Treat CD8+ T-Cell Predominant Acute Hepatitis and Liver Failure. Pediatric Transplantation, 18, 503-509. [Google Scholar] [CrossRef] [PubMed]
[6] Patel, K.R., Bertuch, A., Sasa, G.S., et al. (2017) Features of Hepatitis in Hepatitis-Associated Aplastic Anemia: Clinical and Histopathologic Study. Journal of Pediatric Gastroenterology and Nutrition, 64, e7-e12. [Google Scholar] [CrossRef
[7] Chapin, C.A., Burn, T., Meijome, T., et al. (2018) Indeter-minate Pediatric Acute Liver Failure Is Uniquely Characterized by a CD103+CD8+ T-Cell Infiltrate. Hepatology, 68, 1087-1100. [Google Scholar] [CrossRef] [PubMed]
[8] Li, Y., You, Z., Tang, R., et al. (2022) Tissue-Resident Memory T Cells in Chronic Liver Diseases: Phenotype, Development and Function. Frontiers in Immunology, 13, Arti-cle 967055. [Google Scholar] [CrossRef] [PubMed]
[9] Bianchi, M.E. (2007) DAMPs, PAMPs and Alarm-ins: All We Need to Know about Danger. Journal of Leukocyte Biology, 81, 1-5. [Google Scholar] [CrossRef] [PubMed]
[10] Triantafyllou, E., Woollard, K.J., McPhail, M., et al. (2018) The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure. Frontiers in Immunology, 9, Article 2948. [Google Scholar] [CrossRef] [PubMed]
[11] Woolbright, B.L. and Jaeschke, H. (2017) The Impact of Sterile In-flammation in Acute Liver Injury. Journal of Clinical and Translational Research, 3, 170-188. [Google Scholar] [CrossRef
[12] Heymann, F. and Tacke, F. (2016) Immunology in the Liv-er—From Homeostasis to Disease. Nature Reviews Gastroenterology & Hepatology, 13, 88-110. [Google Scholar] [CrossRef] [PubMed]
[13] Xue, J., Schmidt, S.V., Sander, J., et al. (2014) Transcrip-tome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation. Immunity, 40, 274-288. [Google Scholar] [CrossRef] [PubMed]
[14] Garcia-Martinez, I., Santoro, N., Chen, Y., et al. (2016) Hepatocyte Mitochondrial DNA Drives Nonalcoholic Steatohepatitis by Activation of TLR9. Journal of Clinical Investi-gation, 126, 859-864. [Google Scholar] [CrossRef
[15] Bernsmeier, C., Singanayagam, A., Patel, V.C., et al. (2015) Immunothera-py in the Treatment and Prevention of Infection in Acute-on-Chronic Liver Failure. Immunotherapy, 7, 641-654. [Google Scholar] [CrossRef] [PubMed]
[16] Piano, S., Brocca, A., Mareso, S., et al. (2018) Infections Complicating Cir-rhosis. Liver International, 38, 126-133. [Google Scholar] [CrossRef] [PubMed]
[17] Borst, K., Frenz, T., Spanier, J., et al. (2018) Type I Interferon Receptor Signaling Delays Kupffer Cell Replenishment during Acute Fulminant Viral Hepatitis. Journal of Hepatology, 68, 682-690. [Google Scholar] [CrossRef] [PubMed]
[18] Reid, D.T., Reyes, J.L., McDonald, B.A., et al. (2016) Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation. PLOS ONE, 11, e0159524. [Google Scholar] [CrossRef] [PubMed]
[19] Uderhardt, S., Martins, A.J., Tsang, J.S., et al. (2019) Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage. Cell, 177, 541-555.e17. [Google Scholar] [CrossRef] [PubMed]
[20] Krenkel, O. and Tacke, F. (2017) Liver Macrophages in Tissue Homeostasis and Disease. Nature Reviews Immunology, 17, 306-321. [Google Scholar] [CrossRef] [PubMed]
[21] Tacke, F. (2017) Targeting Hepatic Macrophages to Treat Liver Diseases. Journal of Hepatology, 66, 1300-1312. [Google Scholar] [CrossRef] [PubMed]
[22] MacParland, S.A., Liu, J.C., Ma, X.Z., et al. (2018) Single Cell RNA Sequencing of Human Liver Reveals Distinct Intrahepatic Macrophage Populations. Nature Communications, 9, Article No. 4383. [Google Scholar] [CrossRef] [PubMed]
[23] Bevan, M.J. (2011) Memory T Cells as an Occupying Force. European Journal of Immunology, 41, 1192-1195. [Google Scholar] [CrossRef] [PubMed]
[24] Sun, H., Sun, C., Xiao, W., et al. (2019) Tissue-Resident Lymphocytes: From Adaptive to Innate Immunity. Cellular & Molecular Immunology, 16, 205-215. [Google Scholar] [CrossRef] [PubMed]
[25] Mackay, L.K., Braun, A., Macleod, B.L., et al. (2015) Cutting Edge: CD69 Interference with Sphingosine-1-Phosphate Receptor Function Regulates Peripheral T Cell Retention. The Journal of Immunology, 194, 2059-2063. [Google Scholar] [CrossRef] [PubMed]
[26] Chapin, C.A., Taylor, S.A., Malladi, P., et al. (2021) Transcrip-tional Analysis of Liver Tissue Identifies Distinct Phenotypes of Indeterminate Pediatric Acute Liver Failure. Hepatology Communications, 5, 1373-1384. [Google Scholar] [CrossRef] [PubMed]
[27] Pallett, L.J., Davies, J., Colbeck, E.J., et al. (2017) IL-2High Tissue-Resident T Cells in the Human Liver: Sentinels for Hepatotropic Infection. Journal of Experimental Medicine, 214, 1567-1580. [Google Scholar] [CrossRef] [PubMed]
[28] You, Z., Li, Y., Wang, Q., et al. (2021) The Clinical Significance of Hepatic CD69+CD103+CD8+ Resident-Memory T Cells in Autoimmune Hepatitis. Hepatology, 74, 847-863. [Google Scholar] [CrossRef] [PubMed]
[29] Burkett, P.R., Koka, R., Chien, M., et al. (2004) Coordinate Expression and Trans Presentation of Interleukin (IL)- 15Rα and IL-15 Supports Natural Killer Cell and Memory CD8+ T Cell Homeo-stasis. Journal of Experimental Medicine, 200, 825-834. [Google Scholar] [CrossRef] [PubMed]
[30] Holz, L.E., Prier, J.E., Freestone, D., et al. (2018) CD8+ T Cell Activation Leads to Constitutive Formation of Liver Tissue-Resident Memory T Cells That Seed a Large and Flexible Niche in the Liver. Cell Reports, 25, 68-79.e4. [Google Scholar] [CrossRef] [PubMed]
[31] Thompson, E.A., Darrah, P.A., Foulds, K.E., et al. (2019) Mon-ocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β Release. Cell Reports, 28, 1127-1135.e4. [Google Scholar] [CrossRef] [PubMed]
[32] Pallett, L.J., Burton, A.R., Amin, O.E., et al. (2020) Longevity and Replenishment of Human Liver-Resident Memory T Cells and Mononuclear Phagocytes. Journal of Experimental Medicine, 217, e20200050. [Google Scholar] [CrossRef] [PubMed]
[33] Kurd, N.S., He, Z., Louis, T.L., et al. (2020) Early Precursors and Mo-lecular Determinants of Tissue-Resident Memory CD8+ T Lymphocytes Revealed by Single-Cell RNA Sequencing. Sci-ence Immunology, 5. [Google Scholar] [CrossRef] [PubMed]
[34] Kumar, B.V., Kratchmarov, R., Miron, M., et al. (2018) Func-tional Heterogeneity of Human Tissue-Resident Memory T Cells Based on Dye Efflux Capacities. JCI Insight, 3, e123568. [Google Scholar] [CrossRef] [PubMed]
[35] Pirozyan, M.R., Nguyen, N., Cameron, B., et al. (2019) Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepati-tis C Infection. The Journal of Infectious Diseases, 219, 1430-1438. [Google Scholar] [CrossRef] [PubMed]
[36] Chalin, A., Lefevre, B., Devisme, C., et al. (2018) Serum CXCL10, CXCL11, CXCL12, and CXCL14 Chemokine Patterns in Patients with Acute Liver Injury. Cytokine, 111, 500-504. [Google Scholar] [CrossRef] [PubMed]
[37] Tse, S.W., Radtke, A.J., Espinosa, D.A., et al. (2014) The Chemo-kine Receptor CXCR6 Is Required for the Maintenance of Liver Memory CD8+ T Cells Specific for Infectious Pathogens. The Journal of Infectious Diseases, 210, 1508-1516. [Google Scholar] [CrossRef] [PubMed]
[38] Skon, C.N., Lee, J.Y., Anderson, K.G., et al. (2013) Transcriptional Downregulation of S1pr1 Is Required for the Establishment of Resi-dent Memory CD8+ T Cells. Nature Immunology, 14, 1285-1293. [Google Scholar] [CrossRef] [PubMed]
[39] Huang, B., Lyu, Z., Qian, Q., et al. (2022) NUDT1 Promotes the Accumulation and Longevity of CD103+ T(RM) Cells in Primary Biliary Cholangitis. Journal of Hepatology, 77, 1311-1324. [Google Scholar] [CrossRef] [PubMed]
[40] Kim, J.H., Han, J.W., Choi, Y.J., et al. (2020) Functions of Human Liver CD69+CD103−CD8+ T Cells Depend on HIF-2α Activity in Healthy and Pathologic Livers. Journal of Hepatology, 72, 1170-1181. [Google Scholar] [CrossRef] [PubMed]
[41] Ray, S.J., Franki, S.N., Pierce, R.H., et al. (2004) The Collagen Binding Alpha1beta1 Integrin VLA-1 Regulates CD8 T Cell-Mediated Immune Protection against Heterologous Influen-za Infection. Immunity, 20, 167-179. [Google Scholar] [CrossRef
[42] Cheuk, S., Schlums, H., Gallais, Sérézal, I., et al. (2017) CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity, 46, 287-300. [Google Scholar] [CrossRef] [PubMed]
[43] Chapin, C.A., Melin-Aldana, H., Kreiger, P.A., et al. (2020) Activated CD8 T-Cell Hepatitis in Children with Indeterminate Acute Liver Failure: Results from a Multicenter Cohort. Journal of Pediatric Gastroenterology and Nutrition, 71, 713-719. [Google Scholar] [CrossRef
[44] Liepelt, A. and Tacke, F. (2016) Stromal Cell-Derived Fac-tor-1 (SDF-1) as a Target in Liver Diseases. American Journal of Physiology-Gastrointestinal and Liver Physiology, 311, G203-209. [Google Scholar] [CrossRef] [PubMed]
[45] DeLeve, L.D., Wang, X. and Wang, L. (2016) VEGF-sdf1 Recruit-ment of CXCR7+ Bone Marrow Progenitors of Liver Sinusoidal Endothelial Cells Promotes Rat Liver Regeneration. American Journal of Physiology-Gastrointestinal and Liver Physiology, 310, G739-G746. [Google Scholar] [CrossRef] [PubMed]
[46] Wang, H., Tu, M., Fu, R., et al. (2014) The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China. PLOS ONE, 9, e98142. [Google Scholar] [CrossRef] [PubMed]
[47] Fujiwara, K., Yasui, S., Yonemitsu, Y., et al. (2014) Efficacy of High-Dose Corticosteroid in the Early Stage of Viral Acute Liver Failure. Hepatology Research, 44, 491-501. [Google Scholar] [CrossRef] [PubMed]
[48] Zhao, B., Zhang, H.Y., Xie, G.J., et al. (2016) Evaluation of the Efficacy of Steroid Therapy on Acute Liver Failure. Experimental and Therapeutic Medicine, 12, 3121-3129. [Google Scholar] [CrossRef] [PubMed]
[49] Bernsmeier, C., Antoniades, C.G. and Wendon, J. (2014) What’s New in Acute Liver Failure? Intensive Care Medicine, 40, 1545-1548. [Google Scholar] [CrossRef] [PubMed]
[50] Fernández, J., Clària, J., Amorós, A., et al. (2019) Effects of Al-bumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients with Decompensated Cirrhosis. Gastroenterology, 157, 149-162. [Google Scholar] [CrossRef] [PubMed]
[51] Caraceni, P., Riggio, O., Angeli, P., et al. (2018) Long-Term Al-bumin Administration in Decompensated Cirrhosis (ANSWER): An Open-Label Randomised Trial. The Lancet, 391, 2417-2429. [Google Scholar] [CrossRef
[52] Becares, N., Härmälä, S., China, L., et al. (2020) Immune Regulatory Mediators in Plasma from Patients with Acute Decompensation Are Associated with 3-Month Mortality. Clinical Gastroenterology and Hepatology, 18, 1207-1215.e6. [Google Scholar] [CrossRef] [PubMed]
[53] Wang, X., Sun, R., Wei, H. and Tian, Z. (2013) High-Mobility Group Box 1 (HMGB1)-Toll-Like Receptor (TLR)4- Interleukin (IL)-23-IL-17A Axis in Drug-Induced Dam-age-Associated Lethal Hepatitis: Interaction of γδ T Cells with Macrophages. Hepatology, 57, 373-384. [Google Scholar] [CrossRef] [PubMed]
[54] Zamora, R., Barclay, D., Yin, J., et al. (2019) HMGB1 Is a Central Driver of Dynamic Pro-Inflammatory Networks in Pediatric Acute Liver Failure Induced by Acetaminophen. Scientific Reports, 9, Article No. 5971. [Google Scholar] [CrossRef] [PubMed]
[55] Vodovotz, Y., Barclay, D., Yin, J., et al. (2020) Dynamics of Systemic Inflammation as a Function of Developmental Stage in Pediatric Acute Liver Failure. Frontiers in Immunology, 11, Article 610861. [Google Scholar] [CrossRef] [PubMed]
[56] Lundbäck, P., Lea, J.D., Sowinska, A., et al. (2016) A Novel High Mobility Group Box 1 Neutralizing Chimeric Antibody Attenuates Drug-Induced Liver Injury and Postinjury In-flammation in Mice. Hepatology, 64, 1699-1710. [Google Scholar] [CrossRef] [PubMed]
[57] Wen, Z., Liu, Y., Li, F., et al. (2013) Circulating Histones Exacerbate In-flammation in Mice with Acute Liver Failure. Journal of Cellular Biochemistry, 114, 2384-2391. [Google Scholar] [CrossRef] [PubMed]
[58] Antoniades, C.G., Khamri, W., Abeles, R.D., et al. (2014) Secretory Leu-kocyte Protease Inhibitor: A Pivotal Mediator of Anti-Inflammatory Responses in Acetaminophen-Induced Acute Liver Failure. Hepatology, 59, 1564-1576. [Google Scholar] [CrossRef] [PubMed]
[59] Marra, F. and Tacke, F. (2014) Roles for Chemokines in Liver Disease. Gastroenterology, 147, 577-594.e1. [Google Scholar] [CrossRef] [PubMed]
[60] Mossanen, J.C., Krenkel, O., Ergen, C., et al. (2016) Chemokine (C-C Motif) Receptor 2-Positive Monocytes Aggravate the Early Phase of Acetaminophen-Induced Acute Liver Injury. Hepatology, 64, 1667-1682. [Google Scholar] [CrossRef] [PubMed]